Effects of Intercellular Adhesion Molecule-1 on Renal Damage in Spontaneously Hypertensive Rats

REFERENCES

• Ono H, Ono Y. Nephrosclerosis and hypertension. Med Clin North Am. 1997;81:1273–1288.
   PubMed Web of Science ®Google Scholar
• Feld LG, Van Liew JB, Galaske RG, Boylan JW. Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney Int. 1977;12:332–343.
   PubMed Web of Science ®Google Scholar
• Hilgers KF, Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Nephrol Dial Transplant. 2008;23:3456–3463.
   Google Scholar
• Wang PX, Sanders PW. Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: A primary disorder of vascular smooth muscle. Am J Physiol Renal Physiol. 2005;288:F236–F42.
   Google Scholar
• Paletas K, Boura P, Magoula I, Alexiadis S, Tsapas A. Highly increased ICAM-1 levels in essential hypertension: Correlation to proinflammatory cytokines levels. Am J Hypertens. 1999;12:66a–66a.
   Google Scholar
• Buemi M, Marino D, Floccari F, . Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K(+) in erythrocytes from subjects with essential hypertension. Curr Med Res Opin. 2004;20:19–24.
   PubMed Web of Science ®Google Scholar
• Zhou XJ, Vaziri ND, Zhang J, Wang HW, Wang XQ. Association of renal injury with nitric oxide deficiency in aged SHR: Prevention by hypertension control with AT1 blockade. Kidney Int. 2002;62:914–921.
   PubMed Web of Science ®Google Scholar
• Chung S, Park CW, Shin SJ, . Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Nephrol Dial Transplant. 2010;25:389–399.
   Google Scholar
• Pravenec M, Kajiya T, Zidek V, . Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension. 2011;57:731–737.
   Google Scholar
• Ito Y, Aten J, Nguyen TQ, . Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol. 2011;117:e9–e20.
   Google Scholar
• Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: A viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res. 2009;32:115–121.
   PubMed Web of Science ®Google Scholar
• Palatini P, Mormino P, Dorigatti F, . Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST. Kidney Int. 2006;70:578–584.
   Google Scholar
• Schillaci G, Pirro M, Pucci G, . Is glomerular hyperfiltration a correlate of the metabolic syndrome in never-treated essential hypertension? J Hypertens. 2009;27:S401–S401.
   Google Scholar
• Garg JP, Bakris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7:35–43.
   PubMed Web of Science ®Google Scholar
• van Dokkum RPE, Ochodnicky P, Henning RH, Buikema HJ, de Zeeuw D, Provoost AP. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat. Am J Physiol Renal Physiol. 2010;298:F625–F633.
   Google Scholar
• Imig JD, Knight SF, Yuan JH, Roy S. Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. Am J Physiol Renal Physiol. 2010;298:F86–F94.
   Google Scholar
• Zhong J, Guo D, Chen CB, . Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension. 2011;57:314–322.
   PubMed Web of Science ®Google Scholar
• Niessen HM, Krijnen PA, Visser CA, Meijer CJ, Hack CE. Intercellular adhesion molecule-1 in the heart. Ann N Y Acad Sci. 2002;973:573–585.
   Google Scholar
• Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009;61:22–32.
   PubMed Web of Science ®Google Scholar
• Pickering TG. Stress, inflammation, and hypertension. J Clin Hypertens. 2007;9:567–571.
   Google Scholar
• Frank PG, Lisanti MP. ICAM-1: Role in inflammation and in the regulation of vascular permeability. Am J Physiol Heart Circ Physiol. 2008;295:H926–H927.
   PubMed Web of Science ®Google Scholar
• Witkowska AM. Soluble ICAM-1: A marker of vascular inflammation and lifestyle. Cytokine. 2005;31:127–134.
   PubMed Web of Science ®Google Scholar
• Spencer CG, Martin SC, Felmeden DC, Blann AD, Beevers GD, Lip GY. Relationship of homocysteine to markers of platelet and endothelial activation in “high risk” hypertensives: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Int J Cardiol. 2004;94:293–300.
   PubMed Web of Science ®Google Scholar
• Kashyap MK, Yadav V, Sherawat BS, . Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol Cell Biochem. 2005;277:89–99.
   PubMed Web of Science ®Google Scholar
• Polivoda SN, Cherepok AA. Changes in activity of transcription factors in the cells of vascular endothelium as a pathological mechanism of its dysfunction in essential hypertension. Ter Arkh. 2005;77:59–62.
   Google Scholar
• Tong S, Neboori HJ, Tran ED, Schmid-Schönbein GW. Constitutive expression and enzymatic cleavage of ICAM-1 in the spontaneously hypertensive rat. J Vasc Res. 2011;48:386–396.
   PubMed Web of Science ®Google Scholar
• Mills PJ, von Kanel R, Hong S, Pung MA. Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise. Am J Hypertens. 2007;20:670–675.
   Google Scholar
• Madej A, Okopien B, Kowalski J, Haberka M, Herman ZS. Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Pharmacol Rep. 2005;57:878–881.
   PubMed Web of Science ®Google Scholar
• Glowinska B, Urban M, Peczynska J, Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism. 2005;54: 1020–1026.
   PubMed Web of Science ®Google Scholar
• Lhotta K, Neumayer HP, Joannidis M, Geissler D, Konig P. Renal expression of intercellular-adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci. 1991;81:477–481.
   PubMed Web of Science ®Google Scholar
• Hussein MRA, Abd-Elkareem MI, Al Tamimy HM, Khamis OA, Abdellatif SS. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: Preliminary findings. Clin Exp Nephrol. 2010;14:548–557.
   Google Scholar
• Chen XM, Cai GY, Zhang XG, . Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation. Nephrol Dial Transplant. 2008;23:1861–1875.
   Google Scholar
• Chen XM, Zhang XG, Hong Q, . TIMP-1 promotes age-related renal fibrosis through upregulating ICAM-1 in human TIMP-1 transgenic mice. J Gerontol A Biol Sci Med Sci. 2006;61:1130–1143.
   Google Scholar
• Steadman R, Clayton A. ICAM-1 interactions in the renal interstitium: A novel activator of fibroblasts during nephritis. Histol Histopathol. 1999;14:861–870.
   Google Scholar
• Lan HY, Chen HY, Huang XR, . The protective role of Smad7 in diabetic kidney disease: Mechanism and therapeutic potential. Diabetes. 2011;60:590–601.
   Google Scholar
• Tesar V, Masek Z, Rychlík I, . Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant. 1998;13:1662–1667.
   PubMed Web of Science ®Google Scholar
• Abd-Elkareem MI, Al Tamimy HM, Khamis OA, Abdellatif SS, Hussein MR. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: Preliminary findings. Clin Exp Nephrol. 2010;14:548–557.
   PubMed Web of Science ®Google Scholar
• Montecucco F, Pende A, Quercioli A, Mach F. Inflammation in the pathophysiology of essential hypertension. J Nephrol. 2011;24:23–34.
   PubMed Web of Science ®Google Scholar
• Katsi V, Tsartsalis D, Kontoangelos K, . Inflammation and essential hypertension: A diptych which affects quality of life. J Hypertens. 2010;28:E267–E267.
   Google Scholar
• Bilovol O. Markers of systemic inflammation in essential hypertension. J Hypertens. 2009;27:S370–S371.
   Google Scholar